The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene
Research Funding - Celgene (Inst)
INSPIRE: A randomized phase III trial of intravenous rigosertib in patients with higher-risk myelodysplastic syndromes (HR-MDS) after failure of hypomethylating agents (HMAs)—Study design informed by subgroup analyses of ONTIME.
 
Guillermo Garcia-Manero
No Relationships to Disclose
 
Aref Al-Kali
Research Funding - Onconova Therapeutics (Inst)
 
Maria R. Baer
No Relationships to Disclose
 
Gail J. Roboz
Consulting or Advisory Role - Agios; Amphivena; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Janssen; MEI Pharma; Roche; Shire
Research Funding - Abbvie (Inst); Agios (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); CTI (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); MEI Pharma (Inst); Moffitt (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst); Tensha Therapeutics (Inst)
Travel, Accommodations, Expenses - Amphivena; Astellas Pharma; Astex Pharmaceuticals; AstraZeneca; Celator; Incyte; MEI Pharma; Roche; Shire
 
Uwe Platzbecker
No Relationships to Disclose
 
Suman Kambhampati
Speakers' Bureau - Gilead Sciences
 
Lucy A. Godley
Research Funding - Onconova Therapeutics
Patents, Royalties, Other Intellectual Property - UpToDate
 
Robert Collins
No Relationships to Disclose
 
Jamile M. Shammo
Consulting or Advisory Role - Alexion Pharmaceuticals; Celgene; Incyte; Novartis
Speakers' Bureau - Alexion Pharmaceuticals; Celgene; Incyte; Novartis
Research Funding - Alexion Pharmaceuticals (Inst); Celgene (Inst); Incyte (Inst); Novartis (Inst)
 
Valeria Santini
Consulting or Advisory Role - Celgene; Janssen; Novartis; Onconova Therapeutics
Research Funding - Celgene
 
Dr. Azra Raza
No Relationships to Disclose
 
Lewis R. Silverman
Honoraria - Onconova Therapeutics
Research Funding - Onconova Therapeutics
Patents, Royalties, Other Intellectual Property - Onconova Therapeutics
 
Nozar Azarnia
Employment - Onconova Therapeutics
 
Steven M. Fruchtman
Employment - Onconova Therapeutics
Leadership - Onconova Therapeutics
Stock and Other Ownership Interests - Onconova Therapeutics
Consulting or Advisory Role - Onconova Therapeutics
Research Funding - Onconova Therapeutics
Travel, Accommodations, Expenses - Onconova Therapeutics (I)
 
Barbara R Snyder
Employment - Onconova Therapeutics
Stock and Other Ownership Interests - Onconova Therapeutics
 
Pierre Fenaux
No Relationships to Disclose